No Rights Beyond Collaboration Products Sample Clauses

No Rights Beyond Collaboration Products. Except as may be agreed by RPRP and Introgen after the Effective Date, this Article 13, and Articles 7 and 12 above, shall not be deemed to grant to RPRP rights with respect to the use, in products other than the Collaboration Products, of Introgen Technology incorporated in such Collaboration Products; nor shall such provisions of this Agreement be deemed to restrict Introgen's right to exploit any Introgen Technology in products other than Collaboration Products (subject to Sections 13.5 and 6.2 above).
Sample 1Sample 2Sample 3
AutoNDA by SimpleDocs
No Rights Beyond Collaboration Products. 22 -ii- 4 TABLE OF CONTENTS (CONTINUED)
Sample 1Sample 2
No Rights Beyond Collaboration Products. Except as expressly provided in Section 11.2, nothing in this Agreement shall be deemed to grant to Ciba rights in products or technology other than the Collaboration Products or be deemed to restrict Neurocrine's right to exploit any Neurocrine Technology, as applicable, in products other than Collaboration Products.
Sample 1Sample 2
No Rights Beyond Collaboration Products. Except as expressly provided herein, nothing in this Agreement shall be deemed to grant to JT rights in products or technology other than the Collaboration Products; nor shall any provision of this Agreement be deemed to restrict CG's right to exploit any CG Technology in products other than Collaboration Products. Likewise, except as expressly provided herein, nothing in this Agreement shall be deemed to grant to CG rights in products or technology other than Collaboration Products, nor shall any provision of this Agreement be deemed to restrict JT's right to exploit any JT Technology in products other than Collaboration Products. -------------------- * Certain information on this page has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portion.
Sample 1
No Rights Beyond Collaboration Products. Except as may be agreed by RPRP and Introgen after the Effective Date, this Article 13, and Articles 7 and 12 above, shall not be deemed to grant to RPRP rights with respect to the use, in products other than the Collaboration Products, of Introgen Technology incorporated in such Collaboration Products; nor shall such provisions of this Agreement be deemed to restrict Introgen's right to exploit any Introgen Technology in products other than Collaboration Products (subject to Sections 13.5 and 6.2 above). [*] Certain information on this page has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions.
Sample 1
No Rights Beyond Collaboration Products. Except as expressly provided herein, nothing in this Agreement shall be deemed to grant to Schering rights in products or technology other than the Collaboration Products; nor shall any provision of this Agreement, be deemed to restrict DUSA's right to exploit any DUSA Technology in products other than Collaboration Products or outside the Field or outside the Territory or applicable Product Territory.
Sample 1

Related to No Rights Beyond Collaboration Products

  • Licensed Products Lessee will obtain no title to Licensed Products which will at all times remain the property of the owner of the Licensed Products. A license from the owner may be required and it is Lessee's responsibility to obtain any required license before the use of the Licensed Products. Lessee agrees to treat the Licensed Products as confidential information of the owner, to observe all copyright restrictions, and not to reproduce or sell the Licensed Products.

  • Licensed Technology The term "Licensed Technology" shall mean the ------------------- Licensed Patents, plus all improvements thereto developed by Licensor, and all related data, know-how and technology.

  • New Products You agree to comply with NASD Notice to Members 5-26 recommending best practices for reviewing new products.

  • Licensed Product “Licensed Product” shall mean any article, composition, apparatus, substance, chemical material, method, process or service whose manufacture, use, or sale is covered or claimed by a Valid Claim within the Patent Rights. For clarity, a “Licensed Product” shall not include other product or material that (a) is used in combination with Licensed Product, and (b) does not constitute an article, composition, apparatus, substance, chemical material, method, process or service whose manufacture, use, or sale is covered or claimed by a Valid Claim within the Patent Rights.

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Commercialization License Subject to the terms of this Agreement, including without limitation Section 2.2 and Theravance's Co-Promotion rights in Section 5.3.2, Theravance hereby grants to GSK, and GSK accepts, an exclusive license under the Theravance Patents and Theravance Know-How to make, have made, use, sell, offer for sale and import Alliance Products in the Territory.

  • Licensed Territory Worldwide NIH Patent License Agreement—Exclusive APPENDIX C – ROYALTIES Royalties:

  • Research Collaboration (a) GSK hereby grants to Anacor a non-exclusive, non-royalty bearing license under the GSK IP, solely as and to the extent necessary or important to conduct activities for which Anacor is responsible under the Research Plans during the Research Collaboration Term.

  • Commercialization Activities Within North America, the Parties will use Commercially Reasonable Efforts to Commercialize Licensed Products in the Field. In addition, within North America and subject to Section 2.7.6, the Parties will use Commercially Reasonable Efforts to conduct the Commercialization activities assigned to them pursuant to the Commercialization Plan/Budget, including the performance of detailing in accordance therewith. In conducting the Commercialization activities, the Parties will comply with all Applicable Laws, applicable industry professional standards and compliance policies of Celgene which have been previously furnished to Acceleron, as the same may be updated from time to time and provided to Acceleron. Neither Party shall make any claims or statements with respect to the Licensed Products that are not strictly consistent with the product labeling and the sales and marketing materials approved for use pursuant to the Commercialization Plan/Budget.

  • Competing Products The provisions of Section 21 are set forth on attached Exhibit H and are incorporated in this Section 21 by this reference.

Time is Money Join Law Insider Premium to draft better contracts faster.